About us
Empowering new therapeutics with advanced antibody discovery technologies
At AbTherx, we are redefining therapeutic antibody discovery. We are driven by our passion for creating best-in-class therapeutics by advancing transgenic technologies with rigorous science. The Atlas™ Platform from AbTherx is built on two decades of experience and utilizes evolutionary intelligence to identify diverse and developable human antibody sequences.
We enable the discovery and development of monoclonal and bispecific antibodies against diverse targets, including GPCRs and ion channels, unlocking previously inaccessible therapeutic opportunities and providing drug developers with powerful new technologies. In addition to engineering the Atlas Mice for unmatched performance, our flexible partnership models drive innovation across the industry by catering to the diverse needs of drug developers of all sizes.